Transaction · 0001068754-26-000009

Morrow George J

MORROW GEORGE J, DIR, reported an open-market or private sale at NEUROCRINE BIOSCIENCES INC involving 1226.000000 shares for an estimated $201971.49. Reported holdings after the transaction were 15560.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
NBIXNEUROCRINE BIOSCIENCES INC
Trade date
Nov 03, 2026
Filing date
Nov 03, 2026
View on SEC Insider profile
Disclosed value-$201kShares × reported price
Shares traded1.22k$164.74 per share
Holdings after15.5kDirect
% of reported position traded7.3%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 16,786 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

NBIX price since this filing

Daily closing prices, with the filing date and available return windows
NBIX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -1.6%1w ago +0.3%1d ago +0.0%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001068754-26-000009
Common Stock
Transaction date
Nov 03, 2026
Filed Nov 03, 2026, 11:52 PM · 0d delay
Shares
1,226 sh
$164.74 per share
Estimated value
-$201k
Computed from shares × price
Holdings after
15,560 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Sale Repeat Seller 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The dispositions reported in this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026. Additionally,

  2. Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

  3. F2

    Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $144.32 to $145.28. The Reporting Person has provided to the issuer, and

  4. (9 footnotes)

    will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

  5. F3

    Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $145.35 to $146.34. The Reporting Person has provided to the issuer, and

  6. F4

    Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $146.38 to $147.26. The Reporting Person has provided to the issuer, and

  7. F5

    Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $163.21 to $164.01. The Reporting Person has provided to the issuer, and

  8. F6

    Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $164.22 to $165.20. The Reporting Person has provided to the issuer, and

  9. F7

    Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $165.26 to $166.24. The Reporting Person has provided to the issuer, and

  10. F8

    Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $166.26 to $167.20. The Reporting Person has provided to the issuer, and

  11. F9

    Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $167.27 to $168.18. The Reporting Person has provided to the issuer, and

  12. F10

    Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $168.27 to $169.10. The Reporting Person has provided to the issuer, and

  13. F11

    The option was granted May 22, 2017 and vested in 12 equal monthly installments beginning June 22, 2017. These options were scheduled to expire on May 22, 2027.

Original filing · 0001068754-26-000009
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

NBIX